SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,410 | -75.4% | 15,001 | -6.2% | 0.00% | – |
| Q2 2023 | $5,728 | +13.7% | 16,001 | +14.3% | 0.00% | – |
| Q1 2023 | $5,040 | +42.2% | 14,001 | +249.9% | 0.00% | – |
| Q4 2022 | $3,545 | -60.6% | 4,001 | -33.3% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 6,001 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -14.3% | 6,001 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -50.0% | 6,001 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -26.3% | 6,001 | +20.0% | 0.00% | – |
| Q3 2021 | $38,000 | -20.8% | 5,001 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 5,001 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | +20.6% | 5,001 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | -39.3% | 5,001 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $56,000 | +330.8% | 5,001 | +149.9% | 0.00% | – |
| Q2 2020 | $13,000 | – | 2,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |